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doi:10.1016/j.jmii.2011.12.029Background/Purpose: Salmonella enterica serovar Choleraesuis (S. Choleraesuis) is a highly
invasive zoonotic pathogen that causes bacteremia in humans and pigs. The prevalence of S.
Choleraesuis in man has gradually decreased since the outbreak of foot and mouth disease
in pigs in 1997 in southern Taiwan. The goal of this study was to investigate the change in prev-
alence of S. Choleraesuis carrying the virulence plasmid (pSCV) in human and swine isolates
collected in 1995e2005 and characterize these.
Methods: 380 isolates were collected from human and swine blood samples. Large pSCVs were
determined by PCR and Southern blot analysis. Antimicrobial susceptibility and resistance
genes, and the phylogenetic association of these large pSCV were analyzed.
Results: The number of isolates harboring the large pSCV was significantly reduced, and their
prevalence differed between human and swine isolates. These large pSCVs were a recombinantof Microbiology, Immunology, and Biopharmaceutics, National Chiayi University, 300 University Road,
edu.tw (C. Chu).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
Change in large virulence plasmid of S. Choleraesuis 419of original 50-kb pSCV and R plasmid. In addition, some large pSCVs lacked two pSCV-specific
deletion regions from pef to repC and from traT to samA. These large pSCVs carried the resis-
tance genes blaTEM, aadA2, and sulI, as well as class I integrons of 0.65 and/or 1.9 kb in size,
but were inconjugatible. Phylogenetic analysis demonstrated that the large pSCV evolves inde-
pendently in human and swine isolates.
Conclusion: S. Choleraesuis with large pSCV was significantly reduced after the foot and mouth
disease outbreak and may evolve in human and swine specific isolates.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Of more than 2500 Salmonella enterica serovars, only
serovars Abortusovis, Abortusequi, Choleraesuis, Dublin,
Enteritidis, Gallinarum or Pullorum, Sendai, and Tyhimu-
rium a harbor virulence plasmid (pSCV), which encodes an
8-kb spv operon1 and ranges from 50 kb in S. Choleraesuis to
285 kb in S. Sendai.2 Functions of the pSVs are associated
with genes on the plasmid and include serum resistance,3,4
replication in spleen, proinflammatory response and
engulfment of spleen, and inhibition of the lymphocyte to
react with T cell mitogen.5 In addition, the S. Typimurium
antigen is involved in regulation of IL-12 p40 synthesis,6
survival in the macrophage, and virulence.1,7e11
Recently, recombinant virulence plasmids have been
reported in S. Choleraesuis, S. Dublin and S. Typhimurium by
introduction of antimicrobial resistance genes, the repli-
con, and type IV secretion system12e16. S. Choleraesuis was
the second most prevalent serovar causing salmonellosis in
man in 1991e1996 in Taiwan. Since foot and mouth disease
in pigs occurred in 1997, S. Choleraesuis infection in man
has reduced considerably.17,18 However, multi-drug resis-
tant (MDR) S. Choleraesuis has emerged by gene mutation,
and introduction of R plasmid and integron.12,19e22
Genomic analysis suggests that S. Choleraesuis evolves
independently in man and pig.23 With the emergence of S.
Choleraesuis carrying large drug-resistant pSCVs with blaTEM
for ampicillin and sulI for sulfonamide resistance3 and the
occurrence of foot and mouth disease in pigs, we investi-
gated 380 isolates collected from humans and pigs with
bacteremia to understand the prevalence of S. Choleraesuis
carrying large drug-resistant pSCVs between human and
swine isolates, and the antimicrobial susceptibility and
resistance genes, class I integron, and phylogenetic rela-
tionship of these large pSCVs.Methods
Bacterial sources and identification
In total, 380 S. Choleraesuis isolates were investigated and
included 196 human and 184 swine blood isolates kindly
provided by Chiayi Chang-Gung Memorial Hospital, CDC,
Animal Technology Institute Taiwan, and Animal Disease
Control Center of Chiayi County. Information on most
isolates was published in 200521,23. All isolates were further
identified in our laboratory by O- and H-antigenagglutination tests and routine culture on XDL agar and LB
broth at 37C.
Antimicrobial susceptibility and resistance genes
The disk diffusion method and the guidelines of CLSI stan-
dards were used to determine susceptibility to ampicillin
(AMP, 10 mg), chloramphenicol (CHL, 30 mg), kanamtcin
(KAN, 30 mg), nalidixic acid (NAL, 12 mg), gentamicin (G,
30 mg), streptomycin (STR, 10 mg), tetracycline (TET,
30 mg)24. Escherichia coli ATCC 25922 was used as the
reference strain to validate the results of the antibiotic
susceptibility. Disks were from Becton Dickinson (Sparks,
Maryland, USA).
Primers used for detection of CS region and aadA, blaPSE,
blaTEM, floR, sulI, and tet genes are listed in Table 1. PCR
conditions and reagents were described previously25. Whole
bacteria and purified virulence plasmid DNA were used as
DNA template for PCR amplification. PCR products were
separated in 2% agarose gel and visualized under UV illu-
mination. PCR products were purified and sequenced.
Plasmid profile and characterization of virulence
plasmid
Plasmid number and size were determined by the Kado-Liu
method26 using the standard plasmids of OU7085 (6.6 kb
and 50 kb) and OU7526 (50 kb and 90 kb). Virulence plasmid
was determined by PCR amplification of spvC and Southern
blotting analysis with the PCR product of spvC as probe.
Specific deletions of original 50-kb pSCV were determined
by PCR amplification with the primers H4-pefF (F) and
RepB3 (R) for the pefD-repC deletion and Esam (F) and
TraT4(R) for the traT-samA deletion.12
All large virulence plasmids were purified by Geneaid
Plasmid Midi Kit (Geneaid Biotech Ltd., Taipei, Taiwan) and
then were transformed into E. coli strain pir116. Ampicillin
or chloramphenicol transformants with large pSCVs were
selected. These large pSCVs were purified by Geneaid
Plasmid Midi Kit and digested by restriction enzyme
HindIII. The digested DNA fragments were separated by
0.8% GTG agarose and transferred onto Zetaprobe
membrane (BioRad, Hercules, CA, USA). The whole plasmid
of the 50-kb pSCV of isolate CN36, large 90-kb pSCV of
isolate CN29, and non-pSCV of isolate K12 were used as
probes for Southern blotting analysis. The phylogenetic
relations of the large pSCVs were constructed by Bio-Profil
software (Vilber Lourmat Deutschland GmbH, Eberhardzell,
Table 1 Primers used in this study
Primers Genes Sequences (50 / 30) Product size (bp) Note
SPVC-1 spvC GAGGCGCTGGATGTGCCTGACT0 450 Marker for virulence plasmid
SPVC-2 GAACGTCTGACTCAGGACACTGT
H4-pefF pefD-repC CGAACAGGGTGATGAATGAGAT 859 Specific deletion region of pSCV
RepB3 CGGCGTGAAAGAGCGCATGATGAT0
Esam traT-samA CCCGATAGCCCTGACGAAGAAT 1800 Specific deletion region of pSCV
TraT4 TGTGCTCATCGAACCACACCCT
Pse-F pse GGCTCAATACGGTCTAGACGAGT 156 Ampicillin resistance
Pse-R GGCAATCACACTCGATGATGCGT
STR-F addA2 AGACGCTCCGCGCTATAGAAGT 203 Streptomycin resistance
STR-R CGGACCTACCAAGGCAACGCT
FloR-F floR CTTTGGCTATACTGGCGATG 257 Chloramphenicol resistance
FloR-R GATCATTACAAGCGCGACAG
SulI-F sul1 CGGATCAGACGTCGTGGATGT 355 Sulfamethoxazole resistance
SulI-R TCGAAGAACCGCACAATCTCGT
TETG-F tetG AGCAGCCTCAACCATTGCCGAT 391 Tetracycline resistance
TETG-R GGTGTTCCACTGAAAACGGTCCT
TEM-F blaTEM GAAGATCAGTTGGGTGCACGAGT 550 Ampicillin resistance
TEM-R CAACTTTATCCGCCTCCATCCAGT
50-CS Int GGCATCCAAGCAGCAAG Variable Integron
30-CS AAGCAGACTTGACCTGA
420 J.-I. Tzeng et al.Germany). In addition, the large pSCV of the transformants
were tested for their conjugatibility based on the methods
described previously.27
Statistical analysis
The SAS Chi-square test (2008) was used to investigate the
differences in the prevalence of S. Choleraesuis carrying
large pSCV between two different factors (hosts and
periods) and Student’s t test was performed to analyze the
differences between the two hosts and two periods
individually.Table 2 The plasmid profiles of 196 human and 184 swine isola
Plasmid profile (kb) Sources No. of isolate
Single plasmid
50 kb Human 14
Swine 3
>50 kb Human 30
Swine 14
At least two plasmids
50 þ other plasmids Human 147
Swine 166
>50 þ other plasmids Human 4
Swine 1
No plasmids Human 1
Swine 0
Total Human 196
Swine 184Results
Determination of large pSCVs
Among 380 S. Choleraesuis isolates, 83.7% (318/380) con-
sisted of at least two plasmids in both human and swine
isolates (Table 2). Southern blot and PCR analysis showed
that 99.2% (377/380) isolates consisted of the pSCV, which
was separated into two plasmid types: the original 50-kb
pSCV and the >50-kb recombinant pSCV (Table 2, Fig. 1).
In addition, S. Choleraesuis isolates with single pSCV were
found to be more prevalent in human than swine samplestes
s Spv Size of pSCV (kb)
PCR Southern
14 14 50
3 3
28 28 > 50
13 13
147 147 50
166 166
4 4 >50
0 0
0 0
0 0
193 193
183 183
Figure 1. Plasmid profile (A) and Southern blot analysis (B)
of the virulence plasmids of S. Choleraesuis isolates. M: S.
Choleraesuis OU7526 containing 50-kb pSCV and 90-kb R
plasmid; M2: S. Dublin; lanes 1e7: S. Choleraesuis isolates
SCB103, SCB113, SCB114, SCB115, SCB117, SCB123, and
SCB124.
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Change in large virulence plasmid of S. Choleraesuis 421(Table 2). In contrast to 330 isolates carrying 50-kb pSCV,
only 45 isolates harbored the large pSCV, and there was
a significant difference in prevalence between human and
swine isolates (Table 2 and 3).
In 1997e1998, occurrence of foot and mouth disease
severely damaged pig production in Taiwan. A significant
decrease was found in the prevalence of isolates carrying
large pSCV between the two periods for human isolates
(41.67% before 1998 vs. 14.67% after 1997, p < 0.05) and
swine isolates (34.38% before 1998 vs. 1.31% after 1997;
p < 0.05) (Table 3). After foot and mouth disease, strains
with the large pSCV were found to be significantly higher in
prevalence in human than swine isolates (14.67% in human
vs. 1.31% in swine isolates, p < 0.05).
Characterization of the large pSCV
Apart from those isolates reported in 2001,2 33 isolates
carried large pSCVs ranging from 60 to >140 kb in size and
were resistant at least to AMP, CHL, or TET (Table 4).
Because competent E. coli pir116 is resistant to STR,
presence of STR resistance on the pSCVs was determined
by PCR amplification of the aadA gene, which was found in
all but one large pSCV isolate (Table 4). Furthermore,
these large pSCVs contained the antimicrobial resistance
genes blaTEM and sulI, and 0.65-kb and/or 1.9-kb CS
regions, which included the sat and aadA-dhfr-aadA2
genes, respectively. Previously, we determined two dele-
tions in pefD-repC and traT-samA regions in 50 kb-pSCV.12
Here, PCR examination of these large pSCVs found that
pB22, pB25, pB82, pCN28, and pCN29 lacked the pefD-repC
deletion region, pCY10 and p1030 lacked the traT-samA
deletion region, and pMS19147 was without both deletion
regions (Table 4).
After digestion with HindIII, 50-kb pSCV were separated
into six major fragments: 15.9-kb H1 (parA-incR-tlpA-spv-
RAB), 12.2-kb H2 (rsd-rck-repFIB-pefAC ), 11.8-kb H3 (partial
repFIIA-finO-traX-traT-samA), 3.8-kb H4 (pefD-orf5-rck-
Table 4 Characterization of the large virulence plasmids of S. Choleraesuis isolates
Name of pSCV Sources Plasmid size (kb) Antibiogram Deletion region1 blaTEM aadA2 sulI CS region (kb)
2
A B 1.9 0.65
pB10 Human 90e140 AT D D D D D D e
pB130 Human 90e140 AT D D D D D D e
pB22 Human 140 ACKT e D D D D D e
pB24 Human >140 ACKT D D D D D D e
pB25 Human 140 C e D D D e e D
pB30 Human >140 ACKT D D D D D D e
pB46 Human 90e140 ACT D D D D D D e
pB52 Human 90e140 ACKT D D D D D D e
pB56 Human >140 AKT D D D D D D e
pB63 Human >140 AKT D D D D D D e
pB74 Human 140 ACKT D D D D D D e
pB75 Human 90e140 AK D D D D D D e
pB76 Human 90e140 AT D D D D D D e
pB82 Human 90e140 ACT e D D D D D e
pB85 Human 140 ACKT D D D D e e D
pB97 Human >140 ACT D D D D D D e
pB103 Human 50e90 AC D D D D e e D
pC05 Human 50e90 ACT D D D D e e e
pCN28 Swine >90 CT e D D D e e D
pCN29 Swine >90 CT e D e D e e D
pCN30 Swine 50e90 C D D e D e e D
pCN31 Swine >90 CT D D e D e e D
pCN32 Swine >90 C D D e D e e D
pCN656 Human >90 T D D e D D e e
pCY10 Human 90e140 CT D e e D e e D
pK123 Human 50e90 AC D D D D e e e
pK27 Human >90 CT D D e D D D e
pC34 Chicken >90 ACKT D D D D D D e
pK45 Human >90 ACK D D D D D D e
pMS18403 Human >90 ACT D D D D e e D
pMS19147 Human 90 CT e e e D D D e
pMS22872 Human >90 T D D e e e e e
P1030 Human 50e90 ACT D e D D e e
1 A specific deletion of pSCV in pefD-repC region for A and traT-samA region for B.
2 1.9 kb CS region consists of genes aad-dhfr-aadA2; 0.65 kb consists of sat encoding streptothricin acetyl-transferase.
422 J.-I. Tzeng et al.partial repFIIA), 3.7-kb H5 (spvCD), and 2.6-kb H6 (samB-
parBS ).12,28 DNA fragment profiles of HindIII-digested large
pSCVs showed that changes in fragment size were mostly
found in the larger H1eH3 fragments and few in smaller
H4eH6 fragments (Fig. 2A). The change in the fragment
size or absence of any one of these six fragments suggests
the possible recombination between 50-kb pSCV and R
plasmid in this fragment.
Using the 50-kb pSCV of CN36, R plasmid from isolate
K12, and large pSCV of CN29 as probes, Southern blot
analysis demonstrated that all large pSCVs were recombi-
nants of the 50-kb pSCV and R plasmids. However, we did
not observe any conjugatibility of these large pSCVs. The
phylogenetic relations of the large pSCVs showed that the
plasmid may evolve in man and pig independently because
we observed that all large pSCVs of all human isolates
belong to Cluster A in contrast to Cluster B for all swine
isolates (Fig. 2B).Discussion
The highly invasive and narrow-host S. Choleraesuis can
transmit between man and pig to cause bacteremia in
both hosts and appears to evolve independently in these
species.22,23 In an early study of human isolates collected in
1996e1997, we reported recombination or integration of
50-kb pSCV and R plasmid to form large recombinant pSCVs
of 75e140 kb12, which can increase the plasmid stability
and host fitness under antimicrobial stress. Thereafter, an
increase in isolates carrying large pSCVs could be observed.
However, the prevalence of isolates harboring large pSCVs
significantly decreased in human and swine isolates after
the foot and mouth disease outbreak (Table 3), which led
to the sacrifice of nearly 4 million pigs in 1997 in Taiwan.
With reduction in infection sources from pig to human,
the prevalence of S. Choleraesuis infection in humans
decreased from 2003 to 2007.17 However, isolates carrying
Figure 2. Restriction fragment length polymorphism profiles of representative large virulence plasmids (pSCV) of S. Choleraesuis
(A) and phylogenetic tree of 31 pSCVs (B). (A) Large pSCVs were digested with restriction enzyme HindIII and then separated in 0.8%
agarose at 30 V for 12 hours. M1: HindIII-digested lDNA. Lane 1: OU7085 containing 50-kb plasmid with six HindIII fragments, and
one 6.6-kb sulI plasmid. Lanes 2e8 are isolates 10, 56, 63, CN30, CN31, 25, and KC34. M2: 1 kb size marker. (B) The phylogenetic
tree of 31 large pSCV of S. Choleraesuis from different sources was constructed by Bio-Profil software. H: human isolates, S: swine
isolate, C: chicken isolate as control.
Change in large virulence plasmid of S. Choleraesuis 423the large pSCVs were more prevalent in human than swine
isolates (Table 3). Phylogenetic analysis of all large pSCVs
revealed independent evolutionary origins for human and
swine isolates (Fig. 2B) and confirms that S. Choleraesuis
evolves in man and pig independently.23 In addition, this
dramatic decrease of the isolates carrying large pSCV seems
to be associated with the reduction in the prevalence ofhuman S. Choleraesuis infection,17 implying that large pSCV
may play an important role in infection in man.
Analysis of HindIII-digested patterns of 31 large pSCV
demonstrated diverse recombination sites, mostly located
in the large H1, H2, and H3 fragments, which consist of
repA/repC, pef operon, traTesamB regions, and tlpA and
rlgA genes. A gene located in the 5’ of the pef operon and
424 J.-I. Tzeng et al.rlgA encodes a probable site-specific recombinase.28 The
recombinant large pUO-StVR2 of S. Typhimurium showed
common variations in IncFIB/repA2, rck and the pef
operons,29 Additionally, p9131 revealed the rckwsrgC
region as a recombination hotspot.15 In the present study,
our results also demonstrated eight large pSCVs lacking
either pefD-repC or traT-samA deletion regions (Table 4),
suggesting that the flanking areas of these two regions may
be hotspots for recombination.
In contrast to 314 isolates harboring the original 50-kb
pSCV and an extra R plasmid, we only obtained 45 isolates
that carried large pSCV with considerable genetic changes,
and these were significantly reduced in prevalence in
human and swine isolates after the foot and mouth disease
outbreak (Tables 2, 3 and 4). These results imply the clonal
dissemination (Fig. 2B) or plasmid conjugation of the large
pSCV. However, 50-kb pSCV lacks the oriT and is unable to
effect conjugation or mobilization27. It is possible that
large pSCV can become conjugatible through recombination
with R plasmid as has occurred in S. Typhimurium.15
However, we did not find that any large pSCVs were con-
jugatible, indicating the R plasmids may be inconjugatible
or have lost their conjugability during recombination.
Similar to the earlier report,12 this study observed the
presence of blaTEM and sul on the large pSCV (Table 4).
The gene sulI was located in 1.9-kb class I integron con-
taining aadA-dhfr-aadA2, which was also identified in the
R plasmid of S. Choleraesuis25,26 and the recombinant
plasmids of S. Typhimurium.14,16,30 Host bacteria carrying
this large multidrug-resistant pSCV can increase their
fitness in an antimicrobial environment. Because of the
existence of antidote system genes, the ccdAB operon on
the pSCVs ensures stable plasmid existence in their host
serovar.28,31,32 Although antimicrobial stress frequently
induces the emergence of the recombinant drug-resistant
plasmids, these recombinant plasmids are not stable and
evolve more quickly to cause more variations in plasmids
such as deletions when the stress is removed. With similar
evolutionary origins in the present study (Table 4, Fig. 2),
these large pSCV changed considerably in size, CS region,
and antimicrobial resistant genes indicating that recombi-
nation can recur in the R plasmid to remove the drug-
resistance gene.33,34 Because of the relatively small
number before 1998, the possibility of sampling bias could
not be ruled out and the representative sampling may not
be good enough to indicate which S. Choleraesuis isolates
were carrying large pSCV in that period.
In conclusion, a reduction of isolates carrying large pSCV
was observed after foot and mouth disease in pig and
may be associated with decrease in prevalence of S. Chol-
earesuis in humans. These large pSCVs were multi-drug
resistance and differed in restriction fragment length
polymorphism pattern between human and swine isolates.Acknowledgments
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